Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer

Conditions: Endometrial Cancer Interventions: Diagnostic Test: MRD-ctDNA Sponsors: The First Hospital of Jilin University; Geneplus-Beijing Co. Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials